March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

November 07, 2024

AI in Neuropathology: How Language Models Are Transforming Brain Tumor Diagnosis

New research explores how integrating AI with clinical guidelines can enhance diagnostic precision for complex brain tumors.

Conexiant

February 12, 2025

FDA & EMA: Submitted Trial Data Discrepancies

Sample size discrepancies were identified in 13 trials (65%), with 8 differing by more than 10%.

Conexiant

September 30, 2024

New DNA Test Accurately Differentiates Between Thymic Tumors

Misdiagnosis can lead to inappropriate treatment, potentially subjecting patients to unnecessary toxicity or, conversely, inadequate treatment for a life-threatening cancer.

Conexiant

September 26, 2024

T Cell Spatial Patterns Linked to CRC Survival

Study links shorter T-cell proximity to cancer cells with improved survival rates in colorectal cancer.

Conexiant

September 26, 2024

Breast Cancer Diagnosis: 55% Gain in Efficiency With AI-Assisted Pathology

AI technology aids pathologists in improving diagnostic speed and accuracy in the challenging task of detecting breast cancer metastases in lymph nodes.

Conexiant

January 15, 2025

Achalasia: Candida's Role in Cancer Risk

New study links esophageal Candida infection to significant cancer risk increase in achalasia patients.

Conexiant

January 24, 2025

CRC Risk: Comparing BMI with Central Obesity Metrics

New evidence links central obesity measures to higher colorectal cancer risk compared to body mass index.

Conexiant

February 19, 2025

FDA Approves Amneal’s Lenalidomide; Mesalamine 800 mg Launched

Mesalamine 800 mg delayed-release tablets have been launched, and FDA approval has been granted for lenalidomide, with plans for entry into the U.S. generic market in 2026.

Conexiant